Page 112 - 16Neonatal Jaundice_compressed
P. 112

Recognition





                         bilirubin from the forehead as 70% of the serum bilirubin limit (300 micromol/litre or 10% of
                         bodyweight in grams for ill babies and 50 micromol/litre  higher for healthy babies), the
                         sensitivity and specificity in Group 1 babies  was 99%  and 45%, and for Group 2 100% and
                         81%, respectively. [EL III]
                                                               44
                         The fourth study was conducted in the UK  in a regional teaching hospital and  included all
                         babies in the postnatal  ward who were having blood taken for serum bilirubin estimation. A
                         concurrent transcutaneous  bilirubin reading (using  BiliChek)  was taken but the site was not
                         specified. A total of 300 babies with gestational age ranging from 33 to 42 weeks were included
                         in this study. Of these, 18.3% of them had serum bilirubin levels  > 250 micromol/litre.
                         Significant correlation  was  seen between  serum bilirubin levels and transcutaneous bilirubin
                         readings (r = 0.77; P < 0.001). Although the BiliChek underestimated serum bilirubin levels by
                         a small value (mean difference −10.6 micromol/litre), the confidence intervals of the difference
                         were  wide, ranging from  −80 to +60 micromol/litre. This discrepancy  was  not found to
                         increase  with  rises  in  bilirubin  levels.  With  a  threshold  value  of  > 195 micromol/litre,
                         transcutaneous bilirubin measurements using BiliChek could detect serum bilirubin levels
                         > 250 micromol/litre with a sensitivity of 91% and a specificity of 66%. [EL II]
                                                            79
                         The fifth study was conducted in Italy   to evaluate  BiliChek in preterm babies. The study
                         population  comprised  340 preterm babies  with gestational age  between 30 to 36 weeks
                         admitted to the neonatal unit of a tertiary hospital. The mean birthweight of the  sample  was
                         2145 ± 518 g. The unit followed a policy of daily bilirubin monitoring for all preterm babies in
                         the first 120 hours of life. After randomly selecting one of these observations, transcutaneous
                         bilirubin was measured from the forehead about 10 minutes before drawing blood for serum
                         bilirubin estimation. All transcutaneous  bilirubin measurements  were made  by the  same
                         investigator, who was blinded to the serum bilirubin results. The correlation coefficient between
                         the  two  measurements  was  0.79  (P < 0.01).  The  BiliChek  reading  overestimated  serum
                         bilirubin level by more than 8.5 micromol/litre in 61% of the sample (209/340), with a mean
                         difference of 18.8 micromol/litre. This difference  was found to increase at higher levels of
                         bilirubin. The most effective transcutaneous bilirubin threshold values were 111 micromol/litre
                         to detect serum bilirubin levels  > 171 micromol/litre  (sensitivity  100% and specificity 40%)
                         and 171 micromol/litre to detect serum bilirubin levels > 205 micromol/litre (sensitivity 100%
                         and specificity 72%). [EL Ib]
                                                     80
                         In the sixth study, from Nigeria,  transcutaneous bilirubin measurements with BiliChek were
                         correlated with serum bilirubin values in a group of African babies with varying degrees of skin
                         pigmentation. The study was conducted at two hospitals; one in a rural setting and the other a
                         tertiary teaching hospital. The study population comprised 127 term and preterm babies with
                         jaundice. Transcutaneous bilirubin measurements were taken from the forehead simultaneously
                         with  blood  sampling  before  phototherapy  was  started.  Skin  pigmentation  was  determined  by
                         visual observation and classified as light (54%  of  babies), medium (36%) and dark (10%).
                         Transcutaneous bilirubin measurements at the forehead correlated well with the serum bilirubin
                         values (r = 0.92;  P < 0.001) when the data were combined from the two hospitals, and the
                         mean difference was 8.5 ± 129.2 micromol/litre. When the data were segregated according to
                         serum bilirubin, correlation for serum bilirubin ≥ 205 micromol/litre was better compared with
                         serum bilirubin levels  < 205 micromol/litre  (r = 0.84  versus  0.67). At serum bilirubin levels
                         ≥ 205 micromol/litre,  transcutaneous  bilirubin  measurements  underestimated  serum  bilirubin
                         with a mean difference of 21.4 micromol/litre, but overestimated it when serum bilirubin levels
                         were  < 205 micromol/litre  (mean difference of 35.7 micromol/litre). When the data were
                         analysed on the basis of skin pigmentation, transcutaneous bilirubin measurements correlated
                         strongly  with  all  three  degrees  of  pigmentation.  Although  the  mean  difference  between
                         transcutaneous  bilirubin  and  serum  bilirubin  readings  was  small  (8.5 micromol/litre),  the
                         imprecision  (standard deviation)  increased with increasing  degree  of pigmentation:
                         92 micromol/litre  for light, 133 micromol/litre  for medium, and 197 micromol/litre  for dark
                         pigmentation. [EL II]

                                                     81
                         In the last study, from the  USA,  transcutaneous bilirubin measurements  with BiliChek  were
                         compared with serum bilirubin levels obtained by the diazo and the VITROS® methods. The
                         study  was conducted in a well-baby  nursery at a  general hospital. The study population
                         comprised 177 term and preterm babies  with  suspected jaundice. Transcutaneous bilirubin


                                                                                                         83
   107   108   109   110   111   112   113   114   115   116   117